Stay updated on Venetoclax and Dinaciclib in AML Clinical Trial
Sign up to get notified when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.

Latest updates to the Venetoclax and Dinaciclib in AML Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page, representing a minor version update to the ClinicalTrials.gov entry. No study data or user-facing content appears to be affected.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe page revision indicator was updated from v3.6.2 to v3.6.3, signaling a minor update to the ClinicalTrials.gov study page.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This indicates a recent site release.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study page now states that no participants are being recruited and adds new help/navigation sections such as How to Read a Study Record, Common Questions, and How to Join a Study, along with an Intervention/Treatment heading. The revision tag was updated to v3.6.0 and the older v3.5.5 tag was removed.SummaryDifference0.5%

- Check60 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, indicating a minor behind-the-scenes update to the study record. This change represents an updated page version rather than a modification to the study data or publicly visible content.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision tag Revision: v3.5.4 is displayed, replacing Revision: v3.5.3, indicating a platform release update. This change does not modify the study data or how users access the page.SummaryDifference0.1%

Stay in the know with updates to Venetoclax and Dinaciclib in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax and Dinaciclib in AML Clinical Trial page.